# Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

> **NCT02812446** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 88 (actual)

## Conditions studied

- Staphylococcal Infection

## Interventions

- **OTHER:** IAI infection
- **OTHER:** Staphylococcus aureus nasal carriage infection

## Key facts

- **NCT ID:** NCT02812446
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-09
- **Final completion:** 2013-12
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02812446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02812446, "Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02812446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*